Close menu




February 19th, 2021 | 09:30 CET

Meyer Burger Technology AG, Relay Medical Corp., Pollux Properties Ltd. - Watch out: These shares from the "penny lane" have excellent upside potential!

  • Investments
Photo credits: pixabay.com

What does a hairdresser who collects photos of his customers, a banker who doesn't wear a raincoat even in the pouring rain, and a pretty nurse selling poppies have in common? That's right, according to a Beatles classic published in 1967, they all live in what is probably Liverpool's most famous street - Penny Lane. In terms of share price, this also includes the shares of the Swiss Company Meyer Burger Technology AG (solar technology), the Canadian Company Relay Medical Corp. (healthcare) and the Singalese real estate Company Pollux Properties Ltd. But for how much longer?

time to read: 4 minutes | Author: Carsten Mainitz
ISIN: CH0108503795 , CA75943L1058 , SG1I77884290

Table of contents:


    Meyer Burger Technology AG - Surprising buy recommendation of the US investment bank Jefferies boosts the share price

    Meyer Burger Technologies Ltd is a solar supplier based in Gwatt, Switzerland, in Bern's canton. Previously specializing in innovative systems and production equipment along the value chain for solar modules, the globally active group had recently announced its intention to enter solar module production itself with its proprietary Heterojunction/SmartWire technology. The background to this is the significantly improved efficiency and yield compared with the PERC technology previously used in production and other heterojunction modules currently available.

    Production is to be set up at the Company's two new German sites in Bitterfeld-Wolfen and Freiberg. The Company had received a funding commitment of EUR 7.5 million from the state of Saxony-Anhalt for the development. The announcement initially caused astonishment in the industry due to the enormous risks of setting up a new production facility in a high-wage country such as Germany. Still, after an analysis, the US investment bank Jefferies also concludes that even if the worst-case scenario were to occur (sales of CHF 400 million, EBITDA margin of 25%), the share price is currently trading at a discount of around 40% compared with comparable solar module producers. And this even though the share has already gained about 27% since the beginning of the year.

    In the best-case scenario (sales of CHF 450 million, EBITDA margin of 30%), analysts even consider a price of around 92 centimes or EUR 0.85 possible. Investors who firmly believe in the energy turnaround currently still have the opportunity to jump on this potential doubling bandwagon.

    Pollux Properties Ltd. - Lots of potential, even without "Castor"

    A little excursion: Pollux in the constellation Gemini is together with its "brother" Castor, one of the brightest bodies in our night sky. But the star, which is one of the red giants, has already passed its prime. It has already burned all the hydrogen in its core to form helium. Fortunately, Pollux has so much mass that it can now fuse its helium into carbon, which will give it another few million years of life. The situation is similar in the showcase city-state of Singapore: here, too, virtually all the building land has now been "burned up," i.e., built on.

    But this is precisely why the real estate market in this booming metropolis is on a continuous upward trend. Price increases have averaged around 13% p.a. over the last five years. Fortunately, real estate developer and portfolio holder Pollux Properties can draw on an extensive real estate portfolio of both residential and office and retail space in this environment. Although the real estate development sub-segment came to a standstill in 2020, the Company was still able to increase its sales by 6% to SGD 15 million using the existing properties and the third pillar, fund management, despite Corona. In fund management, the Company expects a substantial increase in assets under management, which is currently still around SGD 10 million.

    The Company, which is currently capitalized at around EUR 69 million, is sitting on a cash position equivalent to around EUR 7.2 million, with a price-to-book ratio of just 0.56. Value investors, in particular, should therefore take a very close look at this stock. The Pollux share offers a favorable entry opportunity to profit from the ongoing Singapore boom.

    Relay Medical Corp. - Out of the price slump thanks to Corona?

    While most industries are groaning under the effects of the global Corona pandemic, shares of Canadian Company Relay Medical Corp. owe them their rapid climb out of the share price cellar. Founded in 2014 under the name ChroMedX, the MedTech manufacturer's shares had been languishing below a price of CAD 0.30 for more than two years. The announcement of the development of a mobile COVID-19 rapid test device and the construction of a test platform in cooperation with Fio Corporation and its licensing to the North American government agency USAID initially sent investors into raptures.

    The next kick came with the announcement of a successfully completed randomized, double-blind Phase II clinical trial of a COVID-19 therapy called ArtemiC™, developed by Relay's subsidiary Glow LifeTech in collaboration with Swiss PharmaCan AG and Australia's MGC Pharmaceuticals Ltd. The product, manufactured using a technology called MyCell™, statistically significantly increased the recovery of COVID-19 patients in the treatment group compared to a placebo group. Glow LifeTech, which holds exclusive rights to this technology for the US, Canada and Mexico, has now also secured exclusive sales and distribution rights for the therapy in the North American and Caribbean markets. The Phase III clinical trial with a subject number of at least 250 is expected to start shortly in Brazil.

    Should this Phase III trial confirm the results of the Phase II study, this should have an extremely positive effect on Relay's share price. The share, which has more than doubled in value since the beginning of the year, still offers a good investment opportunity for courageous investors.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.

    Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on news.financial. These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.

    The acquisition of financial instruments entails high risks that can lead to the total loss of the capital invested. The information published by Apaton Finance GmbH and its authors are based on careful research on careful research, nevertheless no liability for financial losses financial losses or a content guarantee for topicality, correctness, adequacy and completeness of the contents offered here. contents offered here. Please also note our Terms of use.


    Der Autor

    Carsten Mainitz

    The native Rhineland-Palatinate has been a passionate market participant for more than 25 years. After studying business administration in Mannheim, he worked as a journalist, in equity sales and many years in equity research.

    About the author



    Related comments:

    Commented by Fabian Lorenz on June 29th, 2022 | 12:18 CEST

    Buy or sell? Nel, Zalando, Aspermont under analyst review

    • Commodities
    • Investments
    • Hydrogen
    • Mining

    After the heavy losses of the past months, a countermovement seems to be starting at the moment. Whether this will turn into a real summer rally remains to be seen. Buy or sell is the question. Analysts see a price potential of over 50% for Nel ASA. Even though competition from China and India is increasing. Aspermont also appears attractive at the current price level. The latest quarterly figures were positive, and the positioning of the small-cap in the booming commodities sector is promising. At Zalando, analysts react to the profit warning, and the price targets are significantly reduced. Nevertheless, some advise buying the online fashion retailer, but not everyone.

    Read

    Commented by André Will-Laudien on June 24th, 2022 | 11:19 CEST

    TUI, Pathfinder Ventures, Lufthansa - The travel market is back - where are the share prices?

    • travel
    • Investments
    • Camping

    The travel market has changed dramatically since 2019 in light of the Corona pandemic. Due to the most extensive pandemic standstill in 2020, the capacities for flights, rail traffic and accommodation were adjusted downwards dramatically. Major cost reductions occurred primarily through de-occupancy and staff reductions. Travel companies cut their basic capacity utilization with partners to such an extent that many smaller operations had to pull out of the race, and large corporations could only survive with extensive state aid. Now, however, the situation has turned 180 degrees and demand for travel is exploding. However, this time it seems difficult to ramp up the reduced capacities in line with demand. We look at the opportunities of three typical industry players.

    Read

    Commented by Armin Schulz on June 24th, 2022 | 10:15 CEST

    Commerzbank, Triumph Gold, Bitcoin Group - Inflation alert! Which stocks bring returns in this market environment?

    • Gold
    • Crypto
    • Investments

    We have not seen such high inflation for decades. Looking back, it becomes clear that one cannot compare the situation back then with today. Back then, interest rates were at 12%, and as a saver, you could generate an increase in value for your money despite inflation. Today, interest rates are much lower than inflation. Putting money in a savings account will not bring any investor a profit. If you want to protect your money, the first thing that comes to mind is gold because it is considered crisis-proof. But nowadays, it almost seems as if cryptocurrencies could outperform gold. Alternatively, one can bet on stocks that cover these areas. We take a closer look at three companies.

    Read